Tech Breakthrough & Commercial Acceleration: Practical Pathways for Brain-Computer Interface from Innovation to Market
Neuralink
Brain-Computer Interface System Developer
VCBeat
Internet Medical Health Media
The brain-computer interface (BCI) industry is currently at a critical juncture where technological breakthroughs converge with commercialization. Multi-dimensional resonance among policy, technology, and capital is accelerating industry advancement. The Ministry of Industry and Information Technology, together with six other departments, jointly issued the Action Plan for the Development of the Brain-Computer Interface Industry, explicitly designating BCI as a key track for future industries and setting forth the goal of establishing a robust clinical translation system, thereby charting a clear path for industry development. Meanwhile, medical insurance policies are gradually tilting toward innovative medical technologies, paving the way for the clinical deployment of BCI devices.
In the technological race, Neuralink is advancing human clinical trials to explore the restoration of motor function in paralyzed patients and the practical application of thought-controlled robotic arms in office settings. In China, the first prospective trial of an invasive brain-computer interface (BCI) has been completed, while non-invasive devices have achieved phased progress in the adjunctive treatment of depression. Meanwhile, continuous breakthroughs are being made in flexible electrodes and Chinese EEG signal decoding technologies. On the capital front, global investment and financing enthusiasm remains strong, with leading domestic institutions intensifying their strategic layouts and early-stage projects continuing to garner significant interest.
VCBeat provides in-depth insights into this trend,Focusing on hot topics and core issues in innovative asset transactions, and centering on key buyer groups such as strategic, financial, and industrial investors, we will launch the online live streaming series “China Innovative Medical Asset Living Room.”，In-depth Analysis of Transaction Underlying Logic, Breakdown of Practical Cases, Sharing Frontier Market Insights and Operational Experience, Building an Efficient Platform for Knowledge Exchange, Target Selection, and Resource Interconnection for the Buy-Side Community.
November 18 (Tuesday), 15:00, the “China Innovative Medical Asset Reception Room” transaction co-hosted by VCBeat, Heying Capital, and WeijieyaoRoundtable Discussion, Episode 6, featuringXiong Shuirou, Partner at Hejun Capital (Moderator); Bai Hao, Head of the Brain-Computer Interface Industry at Tianjin Binhai High-Tech Zone; Li Xiaojian, Founder of Weiling Medical; Ni Hualiang, Founder of Aoyi Technology; Yang Xun, Investment Director at Sanbo Brain Hospital; Zhang Yutao, Investment Director at Heying Capital; Zhao Yun, Founder of Xinyun MedicalSeven guests centered around【Technological Breakthrough · Accelerated Translation: Brain-Computer Interfaces from Technical Breakthroughs to CommercializationPractical Implementation Path]MainThrough divergent discussions, we provide actionable trading logic and insights into frontier sector layouts for buy-side investors, establishing a "strategic think tank" for healthcare innovation asset transactions. This empowers the buy side to efficiently capture high-quality asset opportunities, bridging Chinese healthcare innovation assets with global buyers.
Host: Xiong Shuirou
Partner at Hejun Capital
Currently a Partner at Hejun Capital, he also serves as an Investment Partner at institutions such as Yueyin Medical Fund and Chuangdongfang Capital, and is a founding team member of Yueyin Medical Fund. With over a decade of focus on venture capital in the pharmaceutical and healthcare sectors, he has accumulated an investment portfolio totaling billions of RMB. He has led or participated in investments in key industry enterprises, including Lu Daopei Healthcare, Neusoft Zhirui, Tsingke Biotechnology, Huayin Health, Zhenluo Science, and VCBeat.
Guest: Bai Hao
Head of the Brain-Computer Interface Industry, Tianjin Binhai High-Tech Zone
Currently serves as the Head of the Brain-Computer Interface (BCI) Industry at Tianjin Binhai High-Tech Zone, focusing on BCI industry research, enterprise attraction and incubation, and ecosystem development. Led teams to conduct surveys of multiple enterprises across the upstream and downstream supply chains, actively promoting multi-party collaboration among government, industry, academia, research institutions, finance, end-users, and healthcare providers. Established a full-lifecycle service system encompassing technological innovation, industrial commercialization, capital empowerment, and supporting infrastructure, with the aim of positioning the region as a national leader in the BCI industry.
Guest: Li Xiaojian
Founder of Weiling Medical
Academic appointments include Professor at the Center for Brain Science and Brain-Inspired Intelligence, Greater Bay Area, Southern Medical University, and Senior Engineer (Professor-level) at the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences. Professional affiliations include Vice Chair of the General Group and Chair of the Basic Hardware Group of the China Brain-Computer Interface Industry Alliance; Deputy Director of the Brain-Computer Interface and Brain-Inspired Intelligence Professional Committee of the China Association for Standardization; Member of the Brain-Computer Interface Technology Standardization Committee under the Ministry of Industry and Information Technology; and Member of the Brain Network Neurosurgery Branch of the China Medical Equipment Association, among others.
In 2023, Dr. Li was honored with the Outstanding Young Scholar Award at the inaugural Chinese Brain-Computer Interface “Huanao Award.” Under Dr. Li’s leadership, NeuraMatrix has applied implantable brain-computer interface technology in a disruptive manner to clinical research in brain medicine, pioneering a four-tier service system for patients with brain injuries that encompasses protection, restoration, substitution, and treatment of brain function. The achievement of the “Minimally Invasive Fully Implantable Brain-Computer Interface System for Functional Substitution” was recognized as one of the “Top 10 Advances in Chinese Brain-Computer Interfaces” at the “2024 Huanao Award.”
Guest: Ni Hualiang
Founder of OYMotion
Graduated from the Department of Electronic Engineering, Fudan University,With over 20 years of experience in engineering R&D and management within the electronics technology industry, including 7 years of overseas R&D management experience, and holding more than 30 patented inventions in China and North America. Previously served as Principal Engineer at Qualcomm Canada, leading the design and development of multiple globally leading technologies. Founded Shanghai Aoyi Information Technology Co., Ltd. in 2015 and serves as CEO. Aoyi Technology is a high-tech enterprise specializing in brain-computer interfaces (BCI), electromyographic (EMG) neural interfaces, and intelligent robotics, recognized as a “Specialized, Refined, Differential, and Innovative” enterprise. The company has launched multiple product series, including intelligent bionic hands and neural rehabilitation exoskeletons, holds over 80 core authorized patents, and is committed to enhancing the accessibility of rehabilitation healthcare through technology in frontier fields such as human-computer interaction, while exploring new possibilities for scenario-based applications.。
Guest: Yang Xun
Investment Director, Sanbo Brain Hospital
With extensive experience in corporate strategy training, coaching, and consulting, as well as team management in marketing and sales departments. Areas of expertise include: corporate strategic planning, strategy formulation and execution, and sales management.
With over 20 years of experience as a professional manager across various types of enterprises—including Fortune 500 multinational corporations, state-owned enterprise groups, and listed companies—I possess extensive expertise in corporate development strategy, enterprise management, and sales management. Upon joining foreign-invested enterprises, I emphasized a “growth-oriented strategic focus,” leveraging the Danaher Business System (DBS)—a scientific and effective management tool—to facilitate internal expansion and development, while clearly defining strategic planning and execution objectives. Through years of practical application, I have localized the DBS framework to help domestic companies align with advanced international management practices, maximize operational efficiency, and support more enterprises in achieving rapid and sustainable growth.
Guest: Zhang Yutao
Investment Director, Heying Capital
Successfully initiated and established China’s first special industrial fund for brain-computer interfaces (BCI)—the Tianjin BCI Heying Haihe Haitai Venture Capital Fund. Leveraging the leading Tianjin Key Haihe Laboratory—the Haihe Laboratory for Brain-Computer Interaction and Human-Machine Integration—the fund, as one of the most active BCI-focused special funds, prioritizes BCI as a key investment direction. It engages in comprehensive collaboration with stakeholders across BCI industry development, patent commercialization, sector investment, and clinical expertise.
Zhang Yutao has delved deeply into the brain-computer interface (BCI) industry, leading his fund team to evaluate nearly 180 BCI companies across China, achieving an industry coverage rate of over 95%. This comprehensive assessment encompasses various technological pathways, regions, and application scenarios, fostering multi-level interactions and driving development across the industrial chain. Meanwhile, Zhang Yutao serves as an Industry Advisor for the Brain-Computer Interface Industry in the Binhai New Area High-Tech Zone of Tianjin, a Senior Advisor at the Tianjin Haihe Laboratory of Brain-Computer Interaction and Human-Machine Integration, a Senior Advisor at the Shenzhen Brain Science and Technology Industrial Innovation Center, and an Industry Advisor at the Chongqing Center for Brain and Intelligence Sciences.
Guest: Zhao Yun
Founder of Xinyun Medical
Master of Business Administration (MBA) from China Europe International Business School,Beijing University of Chemical Technology-Deputy Director of the New Cloud Medical New Materials Joint R&D Center,Supervisor of the Zhongguancun Medical Device Industry Technology Innovation Alliance,Beijing Science and Technology Program “AIProject Leader of the "R&D of Closed-Loop Implantable Spinal Cord Stimulator" Project,10+Years of experience in the pain management industry; founder of the China Pain Specialist Medical Consortium.
China Innovative Healthcare Asset Lounge - Transaction Roundtable
“China Innovative Healthcare Asset Lounge” is an online live-streaming program by VCBeat, positioned around the core mission of “connecting China’s healthcare innovation assets with global buyers.” It focuses on high-quality asset transactions in fields such as innovative drugs, high-end medical devices, and digital health, aiming to build a professional platform for strategic, financial, and industrial buyers to “showcase, communicate, and connect.” With the goal of “unlocking the value of China’s innovative assets and facilitating efficient transactions,” the program helps buyer groups capture opportunities in premium assets through precise supply-demand matching, analysis of transaction logic, and sharing of practical experience. Meanwhile, it promotes the conversion and retention of local innovative assets, contributing to the ecosystem development of the Global Life and Health Innovation Asset Buyer Alliance.
“Deal Roundtable,” a sub-column of China Innovation Healthcare Asset Lounge, focuses on the strategies, trends, and regulations governing transactions in innovative healthcare assets. Adopting a “buyer-centric perspective,” it invites members of the Buyer Alliance, seasoned investors, and experts from law firms and investment banks to engage in dialogues around hot topics and pain points in deal-making. Through “benchmark case analysis + strategic insights,” the column provides actionable transaction logic and references for layout in frontier sectors to the buyer community, establishing a “strategic think tank” for innovative healthcare asset transactions and empowering buyers to efficiently capture high-quality deal opportunities.
Scan the QR code to reserve a spot for the live broadcast